Plague: Clinics, diagnosis and treatment

Advances in Experimental Medicine and Biology

Volumn 918, Issue , 2016, Pages 293-312

  Nikiforov, Vladimir V ^a   Gao, He ^b   Zhou, Lei ^c   Anisimov, Andrey ^d  

^a FEDERAL BIOMEDICAL AGENCY OF RUSSIA   (Russian Federation)

^b National Institute for Communicable Disease Control and Prevention   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY AND BIOTECHNOLOGY   (Russian Federation)

Author keywords

Bubonic plague; Plague symptoms; Plague treatment; Pneumonic plague; Septicemic plague

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; CHLORAMPHENICOL; CIPROFLOXACIN; CORTICOSTEROID; DOBUTAMINE; DOPAMINE; DOXYCYCLINE; F1 ANTIGEN; GENTAMICIN; HYPERTENSIVE FACTOR; INOTROPIC AGENT; NORADRENALIN; STREPTOMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIGEN DETECTION; CLINICAL FEATURE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LABORATORY DIAGNOSIS; MENINGITIS; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; NONHUMAN; PHARYNGITIS; PLAGUE; POINT OF CARE TESTING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEPTICEMIA; SEROLOGY; COMMUNICABLE DISEASES, EMERGING; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LABORATORY TECHNIQUE; STANDARDS; YERSINIA PESTIS;

ANTI-BACTERIAL AGENTS; CLINICAL LABORATORY TECHNIQUES; COMMUNICABLE DISEASES, EMERGING; EARLY DIAGNOSIS; HUMANS; PLAGUE; YERSINIA PESTIS;

EID: 84991404753     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-94-024-0890-4_11     Document Type: Chapter

References (40)

1. Williams JE, Harrison DN, Quan TJ, Mullins JL, Barnes AM, Cavanaugh DC. Atypical plague bacilli isolated from rodents, fleas, and man. Am J Public Health. 1978;68(3):262-4.
2. Anisimov AP, Lindler LE, Pier GB. Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev. 2004;17(2):434-64.
3. Rudnev GP. Clinical picture of plague. Moscow: Medgiz; 1940.
4. Rudnev GP. Clinical picture of particularly dangerous infections. Moscow: Meditsina; 1966.
5. Text in League of Nations Treaty Series. 1926;78:230-349.
6. Nikanorov SM. Plague. In: Guidance on acute infectious diseases. Moscow: Leningrad; 1931.
7. Luchshev VI, Zharov SN. Selected lectures on infectious diseases and epidemiology. Moscow: Meditsina; 2004.
8. Butler T. Plague and other Yersinia infections. New York: Plenum Press; 1983.
9. Becker T, Polan JD, Quan T. Plague meningitis - a retrospective analysis of cases reported in the United States 1970-1979. WestJMed. 1987;147:554-7.
10. Kumar A. An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy. Virulence. 2014;5(1):80-97.
11. Zhukov-Verezhnikov NN. The diagnosis of plague and cholera. Moscow: Medgiz; 1943.
12. Chalisov IA, Khazanov AT. Guide to pathologoanatomic diagnosis of the most important infectious diseases of man. Medicine: Leningrad; 1980.
13. Cully Jr JF, Barnes AM, Quan TJ, Maupin G. Dynamics of plague in a Gunnison’s prairie dog colony complex from New Mexico. J Wildl Dis. 1997;33(4):706-19.
14. Hawgood BJ. Alexandre Yersin: discoverer of the plague bacillus, explorer and agronomist. J Med Biogr. 2008;16(3):167-72.
15. Chanteau S, Rahalison L, Ralafiarisoa L, Foulon J, Ratsitorahina M, Ratsifasoamanana L, Carniel E, Nato F. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet. 2003;361(9353):211-6.
16. Hampl J, Hall M, Mufti NA, Yao YM, MacQueen DB, Wright WH, Cooper DE. Upconverting phosphor reporters in immunochromatographic assays. Anal Biochem. 2001;288(2):176-87.
17. Yan ZQ, Zhou L, Zhao YK, Wang J, Huang LH, Hu KX, Liu HH, Wang H, Guo ZB, Song YJ, et al. Rapid quantitative detection of Yersinia pestis by lateral-flow immunoassay and upconverting phosphor technology-based biosensor. Sensor Actuat B-Chem. 2006;119(2):656-63.
18. Zhang PP, Liu X, Wang CB, Zhao Y, Hua F, Li CF, Yang RF, Zhou L. Evaluation of upconverting phosphor technology-based lateral flow strips for rapid detection of Bacillus anthracis Spore, Brucella spp., and Yersinia pestis. Plos One. 2014;9(8):e105305.
19. Butler T. Plague into the 21st century. Clin Infect Dis. 2009;49(5):736-42.
20. Qu S, Shi QH, Zhou L, Guo ZB, Zhou DS, Zhai JH, Yang RF. Ambient stable quantitative PCR reagents for the detection of Yersinia pestis. Plos Neglect Trop D. 2010;4(3):e629.
21. Qi Z, Wu Y, Li Y, Li C, Yang X, Zhang Q, Xin Y, Jin Y, Wei R, Cui Y. 3a-negative Yersinia pestis, China. Infect Dis Transl Med. 2015;1(2):61-2. doi:10.11979/idtm.201502004.
22. Hänsch S, Cilli E, Catalano G, Gruppioni G, Bianucci R, Stenseth NC, Bramanti B, Pallen MJ. The pla gene, encoding plasminogen activator, is not specific to Yersinia pestis. BMC Res Notes. 2004;8:535. doi: 10.1186/s13104-13015-11525-x .
23. Armougom F, Bitam I, Croce O, Merhej V, Barassi L, Nguyen TT, La Scola B, Raoult D. Genomic insights into a new Citrobacter koseri strain revealed gene exchanges with the virulence-associated Yersinia pestis pPCP1 plasmid. Front Microbiol. 2016;7:340.
24. Molsa M, Hemmila H, Katz A, Niemimaa J, Forbes KM, Huitu O, Stuart P, Henttonen H, Nikkari S. Monitoring biothreat agents (Francisella tularensis, Bacillus anthracis and Yersinia pestis) with a portable real-time PCR instrument. J Microbiol Meth. 2015;115:89-93.
25. National Department of Health. National plague control guidelines. Plague control guidelines for South Africa. Pretoria: NDoH; 2008.
26. Kutyrev VV, Sharova IN, Osina NA, Kazakova ES, Eroshenko GA, Plotnikova EA, Piontkovskiy SA, Kulichenko AN, Taran TV, Maletskaya OV, et al. The order of organization and realization of laboratory diagnostics of plague for laboratories of local, regional and federal levels: methodological guidelines MUK. 4.2.2940-11. 2. Moscow: Federal service on customers’ rights protection and human well-being surveillance; 2011. p. 2940-1.
27. Lesson 4. Laboratory issues. http://www.Bt.cdc.gov/agent/plague/trainingmodule/4/ .
28. World Health Organization: Operational guidelines on plague surveillance, diagnosis, prevention and control. http://www.searowhoint/entity/emerging_diseases/documents/ ISBN_9789_92_9022_376_4/en/. 2009.
29. Prevention CfDCa: Basic laboratory protocols for the presumptive identification of Yersinia pestis. Atlanta: Centers for Disease Control and Prevention. http://www.bt.cdc.gov/Agent/ Plague/ype_la_cp_121301.pdf. 2001.
30. Prentice MB, Rahalison L. Plague. Lancet. 2007;369(9568):1196-207.
31. Rollins SE, Rollins SM, Ryan ET. Yersinia pestis and the plague. Am J Clin Pathol. 2003;119(Suppl):S78-85.
32. Poland JD, Dennis DT. Treatment of plague. Plague manual: epidemiology, distribution, surveillance and control. Geneva: World Health Organization; 1999.
33. Perry RD, Fetherston JD. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev. 1997;10:35-66.
34. Prentice MB, Rahalison L. Plague. Lancet. 2007;369:1196-207.
35. Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, et al. Plague as a biological weapon: medical and public health management. Working group on civilian biodefense. JAMA. 2000;283(17):2218-90.
36. Mwengee W, Butler T, Mgema S, Mhina G, Almasi Y, Bradley C, Formanik JB, Rochester CG. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis. 2006;42(5):614-21.
37. Rubinstein E. Bioterrorism: role of antimicrobial agents (Lecture). In: IV IACMAC International conference "Antimicrobial therapy"; Moscow. 2001.
38. Anisimov AP, Amoako KK. Treatment of plague: promising alternatives to antibiotics. J Med Microbiol. 2006;55:1461-75.
39. Dennis DT, Gage KL, Gratz N, Poland JD, Tikhomirov E. Plague manual: epidemiology, distribution, surveillance and control. Geneva: World Health Organization; 1999.
40. Lesson 5. Medical management. http://www.Bt.cdc.gov/agent/plague/trainingmodule/5/.